Search       
 

About CP
Contact Us
Subscribe
Read Weekly eNewsletter
HOME | NEWS | CURRENT ISSUE | BUYER'S GUIDE | ARCHIVES | CALENDAR | RESOURCES | CAREERS

Top News

Page 1 of 68


Alpha-adrenergic alfuzosin not effective for chronic prostatitis pain    Dec 18, 2008
NEW YORK (Reuters Health) - Contrary to expectations, the alpha-adrenergic blocker alfuzosin did not alleviate pain in men with chronic prostatitis in a placebo-controlled study conducted by investigators in the Chronic Prostatitis Collaborative Research Network.
Preexisting diabetes raises mortality risk after cancer diagnosis    Dec 17, 2008
NEW YORK (Reuters Health) - Patients with diabetes are at increased risk of all-cause mortality during long-term follow-up after a diagnosis of cancer, according to a meta-analysis published in the Journal of the American Medical Association for December 17.
Adding radiotherapy to hormone treatment cuts prostate cancer mortality    Dec 15, 2008
NEW YORK (Reuters Health) - Adding local radiotherapy to endocrine treatment can markedly reduce 10-year prostate cancer-specific mortality in men with locally advanced or high-risk local disease, according to a report in the December 16th online issue of The Lancet.
Rheumatoid arthritis may be milder in new millennium    Dec 15, 2008
NEW YORK (Reuters Health) - The results of a study published in the December issue of the Annals of the Rheumatic Diseases suggest that the health status of patients with rheumatoid arthritis improved between 1994 and 2004. Investigators suggest this is most likely the result of better and more aggressive treatments.
Chemotherapy does not delay appearance of castrate-resistant prostate cancer    Dec 12, 2008
NEW YORK (Reuters Health) - In men receiving androgen ablation for advanced prostate cancer, the emergence of castrate-resistant disease is not delayed by three cycles of systemic chemotherapy, according to a report in the Journal of Clinical Oncology published ahead of print on November 24th.
Joint pain is increased in breast cancer patients    Dec 12, 2008
SAN ANTONIO, (Reuters Health) - Joint pain is more common and more severe in women with breast cancer than age-matched controls without breast cancer, researchers reported at the 2008 San Antonio Breast Cancer Symposium (SABCS).
Percent free PSA predicts prostate cancer when serum PSA 2.5 ng/mL or lower    Dec 12, 2008
NEW YORK (Reuters Health) - Among men with a serum prostate-specific antigen (PSA) level of 2.5 ng/mL or lower, the percent free PSA is an accurate predictor of prostate cancer at prostate biopsy, according to findings published in the November 15th issue of the journal Cancer.
Zinc nutritive status linked to osteocalcin in type 1 diabetics    Dec 12, 2008
NEW YORK (Reuters Health) - Zinc intake is directly associated with serum levels of osteocalcin, a marker of bone formation, in patients with type 1 diabetes, US researchers report.
Aspirin, resistant starch of no benefit in Lynch syndrome    Dec 11, 2008
NEW YORK (Reuters Health) - Neither aspirin nor resistant starch given daily for up to 4 years reduces the occurrence of intestinal neoplasms in adults with hereditary nonpolyposis colon cancer (Lynch syndrome), investigators report in the December 11 issue of The New England Journal of Medicine.
Acute rheumatic fever remains common disease in non-Western countries    Dec 11, 2008
NEW YORK (Reuters Health) - The incidence of acute rheumatic fever (ARF) has been falling over time, but rates are still higher in non-Western countries than in the U.S. and Western Europe, according to a report in the December issue of Heart.
Panic attacks linked to higher rates of heart disease    Dec 11, 2008
NEW YORK (Reuters Health) - Coronary heart disease is more common in patients with panic disorder than in the general population, British investigators have found. The risk is particularly elevated among patients below the age of 50, who are also more likely to experience an MI.
High infliximab dose can be reduced without loss of effect in RA    Dec 10, 2008
NEW YORK (Reuters Health) - The benefits of infliximab therapy in rheumatoid arthritis (RA) patients are sustained when the dose is lowered from 5 mg/kg to 3 mg/kg, according to a Dutch report in the November issue of the Annals of the Rheumatic Diseases.
U.S. FDA staff debate data for new female condom    Dec 9, 2008
WASHINGTON (Reuters) - U.S. health regulatory staff have questioned whether there are enough data to show that Female Health Co's latest version of its condom for women prevents pregnancy and sexually transmitted diseases, according to documents released on Tuesday.
Vasomotor symptoms linked to low bone density in infertile premenopausal women    Dec 9, 2008
NEW YORK (Reuters Health) - Among infertile but otherwise healthy premenopausal women, the occurrence of night sweats or other vasomotor symptoms is associated with low bone mineral density (BMD), according to a report in the November issue of Fertility and Sterility.
Women less likely than men to survive ST-elevation myocardial infarction    Dec 8, 2008
NEW YORK (Reuters Health) - Although overall in-hospital mortality rates following an acute myocardial infarction are similar for men and women, women with ST-elevation myocardial infarction (STEMI) face a worse prognosis than men, investigators report in the December 16/23 issue of Circulation. Failure to administer appropriate and timely treatment to women appears to account for gender disparity in outcomes.
Sperm DNA fragmentation reduced after varicocele repair    Dec 8, 2008
NEW YORK (Reuters Health) - Varicocelectomy leads to a significant increase in DNA integrity, according to assays of patients with elevated preoperative levels of sperm DNA fragmentation, researchers report in the November issue of Fertility and Sterility
Carraguard does not prevent vaginal transmission of HIV    Dec 4, 2008
NEW YORK (Reuters Health) - The microbicide Carraguard, a carrageenan-based compound, does not protect women from sexual transmission of HIV, according to results of a phase III clinical trial conducted in South Africa.
Reactive arthritis fairly frequent sequela of enteric infection    Dec 4, 2008
NEW YORK (Reuters Health) - Reactive arthritis may follow as many as one in eight infections with bacterial enteric pathogens, according to a report in the November issue of the Annals of the Rheumatic Diseases.
Inadequate epidural analgesia tied to poorer obstetric outcome    Dec 4, 2008
NEW YORK (Reuters Health) - Failure to sustain adequate epidural analgesia appears to be associated with a greater risk of difficult deliveries, Canadian researchers report in the November issue of the American Journal of Obstetrics and Gynecology.
Multiple sclerosis seen associated with headache    Dec 3, 2008
NEW YORK (Reuters Health) - The frequency of headache in patients with multiple sclerosis (MS) is higher than in the general population, Italian researchers report in the November issue of Cephalalgia.
Enzyme replacement therapy normalizes growth in pediatric Gaucher disease    Dec 3, 2008
NEW YORK (Reuters Health) - Long-term, continuous enzyme replacement therapy (ERT) with alglucerase or imiglucerase in children with Gaucher disease type 1 normalizes linear growth, enhances bone mineralization, and reduces liver and spleen volume, according to data from a large registry study.
Possible link identified between fetal exposure to valproate and autism    Dec 1, 2008
NEW YORK (Reuters Health) - Children whose mothers used sodium valproate to treat epilepsy during pregnancy may be at increased risk of autism spectrum disorders, according to preliminary findings of an ongoing prospective UK study reported in the December 2nd issue of Neurology.
Golimumab effective, safe in treating ankylosing spondylitis    Dec 1, 2008
NEW YORK (Reuters Health) - In patients with ankylosing spondylitis (AS), subcutaneous golimumab is both well tolerated and effective at reducing signs and symptoms of active AS, according to a randomized, double-blind, placebo-controlled, phase III trial.
Alendronate can prevent glucocorticoid-related bone problems    Dec 1, 2008
NEW YORK (Reuters Health) - In premenopausal women on high-dose glucocorticoid (GC) therapy, alendronate protects against bone loss and fracture, according to findings published in the November issue of the Journal of Rheumatology.
Hormone therapy protects against hematuria after radiotherapy for prostate cancer    Dec 1, 2008
NEW YORK (Reuters Health) - In prostate cancer patients treated with high-dose radiotherapy, prior transurethral resection of the prostate (TURP) is associated with an increased risk of late hematuria while long-term hormonal androgen ablation is protective, according to findings published in the November issue of Urology.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35

36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52

53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
Resources
Media Kit
Editorial Advisory Board
Advertiser Index
Writer Guidelines
Reprints
News | Current Issue | Buyer's Guide | Archives | Calendar | Resources | Careers
About CP | Contact Us | Subscribe | Read Weekly eNewsletter
Media Kit | Editorial Advisory Board | Advertiser Index | Writer Guidelines | Reprints
Allied Healthcare
24X7 |  Chiropractic Products Magazine |  Clinical Lab Products (CLP) |  Orthodontic Products |  The Hearing Review
Hearing Products Report (HPR) |  HME Today |  Rehab Management |  Physical Therapy Products |  Plastic Surgery Products
Imaging Economics |  Medical Imaging |  RT |  Sleep Review
Medical Education
SynerMed Communications |  IMED Communications
Practice Growth
Practice Builders
Copyright © 2008 Ascend Media LLC | CHIROPRACTIC PRODUCTS | All Rights Reserved. Privacy Policy | Terms of Service